Safety evaluation and risk assessment of D-limonene

Journal of Toxicology and Environmental Health - Part B: Critical Reviews

Volumn 16, Issue 1, 2013, Pages 17-38

  Kim, Young Woo ^a   Kim, Min Ji ^a   Chung, Bu Young ^a   Bang, Du Yeon ^a   Lim, Seong Kwang ^a   Choi, Seul Min ^a   Lim, Duck Soo ^a   Cho, Myung Chan ^a   Yoon, Kyungsil ^b   Kim, Hyung Sik ^a   Kim, Kyu Bong ^c   Kim, You Sun ^d   Kwack, Seung Jun ^e   Lee, Byung Mu ^a  

^a Sungkyunkwan University   (South Korea)

^b National Cancer Center   (South Korea)

^c Dankook University   (South Korea)

^d Foundation of Korea Cosmetic Industry Institute   (South Korea)

^e Changwon National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLOBULIN; COSMETIC; FLAVORING AGENT; FRAGRANCE; LIMONENE; SOLVENT;

ACUTE TOXICITY; ARTICLE; CARCINOGENICITY; CHRONIC TOXICITY; DEVELOPMENTAL TOXICITY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; ENVIRONMENTAL EXPOSURE; FOOD; GENOTOXICITY; GOVERNMENT REGULATION; HUMAN; IMMUNOTOXICITY; LD 50; LONG TERM EXPOSURE; METABOLITE; MUTAGENICITY; NEUROTOXICITY; NONHUMAN; OXIDATION; PHYSICAL CHEMISTRY; PRACTICE GUIDELINE; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; SAFETY; SKIN IRRITATION; SKIN TOXICITY; TERATOGENICITY; TOXICOKINETICS;

ANIMALS; CARCINOGENS; CYCLOHEXENES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVORING AGENTS; HUMANS; MALE; MAXIMUM ALLOWABLE CONCENTRATION; MICE; RATS; RISK ASSESSMENT; TERPENES;

EID: 84878195789     PISSN: 10937404     EISSN: 15216950     Source Type: Journal    
DOI: 10.1080/10937404.2013.769418     Document Type: Article

References (112)

1. Alden, C. L. 1986. A review of unique male rat hydrocarbon nephropathy. Toxicol.Pathol. 14: 109-111.
2. Altshuller, A. P. 1983. Review: Natural volatile organic substances and their effect on air quality in the United States. Atmos. Environ. 17: 2131-2165.
3. Anderson, B. E., Zeiger, E., Shelby, M. D., Resnick, M. A., Gulati, D., Ivett, J. L., and Loveday, K. 1990. Chromosome aberration and sister chromatid exchange test results with 42 chemicals. Environ. Mol. Mutagen. 16: 55-137.
4. Arey, J., Winer, A. M., Atkinson, R., Aschmann, S. M., Long, W. D., Morrison, C. L., and Olszyk, D. M. 1991. Terpenes emitted from agricultural species found in California's central valley. J. Geophys. Res. 96: 9329-9336.
5. Ariyoshi, T., Arakaki, M., Ideguchi, K., Ishizuka, Y., and Ide, H. 1975. Studies on the metabolism of d-limonene (p-mentha-1, 8-diene): III. Effects of d-limonene on the lipids and drug-metabolizing enzymes in rat livers. Xenobiotica 5: 33-38.
6. Bagley, D., Gardner, J., Holland, G., Lewis, R., Regnier, J. F., Stringer, D., and Walker, A. 1996. Skin irritation: Reference chemicals data bank. Toxicol. In Vitro 10: 1-6.
7. Bicas, J. L., Fontanille, P., Pastore, G. M., and Larroche, C. 2008. Characterization of monoterpene biotransformation in two pseudomonads. J. Appl. Microbiol. 105: 1991-2001.
8. Borghoff, S. J., and Lagarde, W. H. 1993. Assessment of binding of 2, 4, 4-trimethyl-2-pentanol to low-molecular-weight proteins isolated from kidneys of male rats and humans. Toxicol. Appl. Pharmacol. 119:228-235.
9. Borghoff, S. J., Miller, A. B., Bowen, J. P., and Swenberg, J. A. 1991.Characteristics of chemical binding to alpha 2u-globulin in vitro-Evaluating structure-activity relationships. Toxicol. Appl. Pharmacol. 107: 228-238.
10. Broitman, S. A., Wilkinson, J. 4th, Cerda, S., and Branch, S. K. 1996. Effects of monoter-penes and mevinolin on murine colon tumor CT-26 in vitro and its hepatic "metastases" in vivo. Adv. Exp. Med. Biol. 401: 111-130.
11. Cachao, P., Brandão, F. M., Carmo, M., Frazao, S., and Silva, M. 1986. Allergy to oil of turpentine in Portugal. Contact Dermatitis 14: 205-208.
12. Chen, H., Chan, K. K., and Budd, T. 1998. Pharmacokinetics of d-limonene in the rat by GC-MS assay. J. Pharm. Biomed. Anal. 17: 631-640.
13. Christensson, J. B., Johansson, S., Hagvall, L., Jonsson, C,. Börje, A., and Karlberg, A. T. 2008. Limonene hydroperoxide analogues differ in allergenic activity. Contact Dermatitis 59: 344-352.
14. Christensson, J. B., Forsstrom, P., Wennberg, A. M., Karlberg, A. T., and Matura, M. 2009. Air oxidation increases skin irritation from fragrance terpenes. Contact Dermatitis 60: 32-40.
15. Ciccioli, P., Brancaleoni, E., Cecinato, A., Sparapani, R., and Frattoni, M. 1993. Identification and determination of biogenic and anthropogenic volatile organic compounds in forest areas of northern and southern Europe and a remote site of the himalaya region by high-resolution gas chromatography-mass spectrometry. J. Chromatogr. A 643:55-69.
16. Connor, T. H., Theiss, J. C., Hanna, H. A., Monteith, D. K., and Matney, T. S. 1985. Genotoxicity of organic chemicals frequently found in the air of mobile homes. Toxicol. Lett. 25: 33-40.
17. Cosmetic, Toiletry, and Fragrance Association. 2005. Calculation of margin of safety. Adult and baby exposures. Washington, DC: CTFA.
18. Crowell, P. L., Lin, S., Vedejs, E., and Gould, M. N. 1992. Identification of metabolites of the antitumor agent d-limonene capable of inhibiting protein isoprenylation and cell growth. Cancer Chemother. Pharmacol. 31: 205-212.
19. de Almeida, A. A., Costa, J. P., de Carvalho, R. B., de Sousa, D. P., and de Freitas, R. M. 2012. Evaluation of acute toxicity of a natural compound (+)-limonene epoxide and its anxiolytic-like action. Brain Res. 1448: 56-62.
20. de Groot, A. C., and Frosch, P. J. 1997. Adverse reactions to fragrances. A clinical review. Contact Derm. 36: 57-86.
21. Desideri, P., Lepri, L., and Checchini, L. 1991. Organic compounds in seawater and pack ice in Terra Nova Bay (Antarctica). Ann. Chim. 81: 395-416.
22. Dietrich, D. R., and Swenberg, J. A. 1991. The presence of α2u-globulin is necessary for d-limonene promotion of male rat kidney tumors. Cancer Res. 51: 3512-3521.
23. Duetz, W. A., Bouwmeester, H., van Beilen, J. B., and Witholt, B. 2003. Biotransformation of limonene by bacteria, fungi, yeasts, and plants. Appl. Microbiol. Biotechnol. 61: 269-277.
24. European Commission. 2006. Opinion on the report "Emission of chemicals by air fresheners Tests on 74 consumer products sold in Europe" (BEUC report January 2005). Scientific Committee on Health and Environmental Risks (SCHER). http://ec. europa.eu/health/ph-risk/committees/04-scher/docs/ scher-o-026.pdf
25. European Commission. 2010. Cosmetics directive. Council Directive 76/768/EEC. http://eur-lex.europa.eu/LexUriServ/LexUriServ. do?uri=CONSLEG: 1976L0768: 20100301: en:PDF.
26. Evans, D. L., Miller, D. M., Jacobsen, K. L., and Bush, P. B. 1987. Modulation of immune responses in mice by d-limonene. J. Toxicol. Environ. Health A 20: 51-66.
27. Fahrig, R. 1984. Genetic mode of action of cocarcinogens and tumor promoters in yeast and mice. Mol. Gen. Genet. 194: 7-14.
28. Falk, A., Fischer, T., and Hagberg, M. 1991.Purpuric rash caused by dermal exposure to d-limonene. Contact Dermatitis 25: 198-199.
29. Falk-Filipsson, A., Löf, A., Hagberg, M., Hjelm, E. W., and Wang, Z. 1993.d-Limonene exposure to humans by inhalation: Uptake, distribution, elimination, and effects on the pulmonary function. J. Toxicol. Environ. Health A 38: 77-88.
30. Fehsenfeld, F., Calvert, J., Fall, R., Goldan, P., Guenther, A. B., Hewitt, C. N., Lamb, B., Liu, S., Trainer, M., and Westberg, H. 1992. Emissions of volatile organic compounds from vegetation and the implications for atmospheric chemistry. Global Biogeochem. Cycle 6: 389-430.
31. Flamm, W. G., and Lehman-McKeeman, L. D. 1991. The human relevance of the renal tumor-inducing potential of d-limonene in male rats: Implications for risk assessment. Regul. Toxicol. Pharmacol. 13: 70-86.
32. Flavor and Extract Manufacturers Association. 1991. d-Limonene monograph. Washington, DC: FEMA.
33. Florin, I., Rutberg, L., Curvall, M., and Enzell, C. R. 1980. Screening of tobacco smoke constituents for mutagenicity using the Ames test. Toxicology 15: 219-232.
34. Friedrich, K., Delgado, I. F., Santos, L. M., and Paumgartten, F. J. 2007. Assessment of sensi-tization potential of monoterpenes using the rat popliteal lymph node assay. Food Chem. Toxicol. 45: 1516-1522.
35. Gould, M. N. 1997. Cancer chemopreven-tion and therapy by monoterpenes. Environ. Health Perspect. 105: 977-979.
36. Greif, N. 1967.Cutaneous safety of fragrance material as measured by the maximization test. Am. Perfume Cosmet. 82: 54-57.
37. Hard, G. C., and Whysner, J. 1994. Risk assessment of d-limonene: An example of male rat-specific renal tumorigens. Crit. Rev. Toxicol. 24: 231-254.
38. Haworth, S., Lawlor, T., Mortelmans, K., Speck, W., and Zeiger, E. 1983. Salmonella mutagenicity test results for 250 chemicals. Environ. Mutagen. 5: 3-49.
39. Health Canada. 2011. Cosmetic ingredient hotlist. http://www.hc-sc.gc.ca/ cps-spc/cosmet-person/indust/hot-list-critique/hotlist-liste-eng.php (accessed April 7, 2012).
40. Helmig, D., and Arey, J. 1992. Organic chemicals in the air at Whitaker's Forest/Sierra Nevada Mountains, California. Sci. Total Environ. 112: 233-250.
41. Hutte, R. S., Williams, E. J., Staehelin, J., Hawthorne, S. B., Barkley, R. M., and Sievers, R. E. 1984. Chromatographic analysis of organic compounds in the atmosphere. J. Chromatogr. 302: 173-179.
42. IARC (International Agency for Research on Cancer). 1999. d-Limonene. IARC Monogr. Eval. Carcinogen. Risk Hum. 73: 307-327.
43. http://monographs.iarc.fr/ENG/Monographs/vol73/mono73-16.pdf
44. Igimi, H., Nishimura, M., Kodama, R., and Ide, H. 1974. Studies on the metabolism of d-limonene (p-mentha-1, 8-diene): I. The absorption, distribution and excretion of d-limonene in rats. Xenobiotica 4: 77-84.
45. Igimi, H., Hisatsugu, T., and Nishimura, M. 1976.The use of d-limonene preparation as a dissolving agent of gallstones. Am. J. Dig. Dis. 21: 926-939.
46. Igimi, H., Tamura, R., Toraishi, K., Yamamoto, F., Kataoka, A., Ikejiri, Y., Hisatsugu, T., and Shimura, H. 1991. Medical dissolution of gallstones. Dig. Dis. Sci. 36: 200-208.
47. International Programme on Chemical Safety. 1994. Assessing health risks of chemicals: Derivation of guidance values for health-based exposure limits. Geneva, Switzerland: World Health Organization.
48. International Programme on Chemical Safety. 2005. d-Limonene. http://www.inchem.org/documents/icsc/icsc/eics0918.htm (accessed March 19, 2012).
49. Japan Ministry of Health, Labor, and Welfare. 2000. Standards for cosmetics. Ministry of Health and Welfare Notification No. 331. http://www.mhlw.go.jp/english/dl/cosmetics. pdf
50. Jüttner, F. 1988. Quantitative analysis of monoterpenes and volatile organic pollution products (VOC) in forest air of the southern black forest. Chemosphere 17: 309-317.
51. Kanerva, R. L., Ridder, G. M., Lefever, F. R., and Alden, C. L. 1987.Comparison of short-term renal effects due to oral administration of decalin or d-limonene in young adult male Fischer-344 rats. Food Chem. Toxicol. 25: 345-353.
52. Karlberg, A. T., Boman, A., and Melin, B. 1991.Animal experiments on the allergenic-ity of d-limonene-The citrus solvent. Ann. Occup. Hyg. 35: 419-426.
53. Kim, H., Barkey, B., and Paulson, S. E. 2012. Real refractive indices and formation yields of secondary organic aerosol generated from photooxidation of limonene and α-pinene: The effect of the HC/NO(x) ratio. J. Phys. Chem. A 116: 6059-6067.
54. Klecak, G., Geleick, H., and Frey, J. 1977. Screening of fragrance materials for allergenicity in the guinea pig. I. Comparison of four testing methods. J. Soc. Cosmet. Chem. 28: 53-64.
55. Kodama, R., Yano, T., Furukawa, K., Noda, K., and Ide, H. 1976. Studies on the metabolism of d-limonene (p-mentha-1, 8-diene). IV. Isolation and characterization of new metabolites and species differences in metabolism. Xenobiotica 6: 377-389.
56. Kodama, R., Okubo, A., Araki, E., Noda, K., Ide, H., and Ikeda, T. 1977a. Studies on d-limonene as a gallstone solubilizer (VII): Effects on development of mouse fetuses and offspring. Oyo Yakuri 13: 863-873.
57. Kodama, R., Okubo, A., Sato, K., Araki, E., Noda, K., Ide, H., and Ikeda, T. 1977b. Studies on d-limonene as a gallstone solu-bilizer (IX).effects on development of rabbit fetuses and offspring. Oyo Yakuri 13: 885-898.
58. Korea Food and Drug Administration. 2010. Provisions for designation of cosmetic ingredients. KFDA notification no. 2010-99. http://www.kfda.go.kr/ index. kfda?x=0&searchkey=title:contents&mid= 92&searchword= %C8%AD%C0%E5%C7%B 0&y=0&division=&pageNo=1&seq=3401& cmd=v
59. Kyoto Encyclopedia of Genes and Genome. 2012. Limonene and pinene degradation. http://www.genome.jp/kegg-bin/show-path way?map00903 (accessed July 26, 2012).
60. Larsen, S. T., Hougaard, K. S., Hammer, M., Alarie, Y., Wolkoff, P., Clausen, P. A., Wilkins, C. K., and Nielsen, G. D. 2000. Effects of R-(+)-and S-(-)-limonene on the respiratory tract in mice. Hum. Exp. Toxicol. 19: 457-466.
61. Lehman-McKeeman, L. D., and Caudill, D. 1992. Biochemical basis for mouse resistance to hyaline droplet nephropathy: Lack of relevance of the alpha 2u-globulin protein super-family in this male rat-specific syndrome. Toxicol. Appl. Pharmacol. 112: 214-221.
62. Lehman-McKeeman, L. D., Rodriguez, M. I., and Caudill, D. 1990. Lysosomal degradation of alpha2μ -globulin and alpha2μ -globulin-xenobiotic conjugates. Toxicol. Appl. Pharmacol. 103: 539-548.
63. Maisey, J., and Miller, K. 1986. Assessment of the ability of mice fed on vitamin A supplemented diet to respond to a variety of potential contact sensitizers. Contact Dermatitis 15: 17-23.
64. Maksymiuk, C. S., Gayahtri, C., Gil, R. R., and Donahue, N. M. 2009. Secondary organic aerosol formation from multiphase oxidation of limonene by ozone: Mechanistic constraints via two-dimensional heteronuclear NMR spectroscopy. Phys. Chem. Chem. Phys. 11: 7810-7818.
65. Matura, M., Goossens, A., Bordalo, O., Garcia-Bravo, B., Magnusson, K., Wrangsjö, K., and Karlberg, A. T. 2002. Oxidized citrus oil (R-limonene): A frequent skin sensi-tizer in Europe. J. Am. Acad. Dermatol. 47: 709-714.
66. Matura, M., Goossens, A., Bordalo, O., Garcia-Bravo, B., Magnusson, K., Wrangsjö, K., and Karlberg, A. T. 2003. Patch testing with oxidized R-(+)-limonene and its hydroperoxide fraction. Contact Dermatitis 49: 15-21.
67. Matura, M., Sköld, M., Börje, A., Andersen, K. E., Bruze, M., Frosch, P., Goossens, A., Johansen, J. D., Svedman, C., White, I. R., Karlberg, A. T. 2006. Not only oxidized R-(+)-but also S-(-)-limonene is a common cause of contact allergy in dermatitis patients in Europe. Contact Dermatits 55: 274-279.
68. McCreary, J. J., Jackson, J. A. G., and Zoltek, J., Jr. 1983. Toxic chemicals in an abandoned phenolic waste site. Chemosphere 12: 1619-1632.
69. National Board of Occupational Safety and Health. 1993. Occupational exposure limit value. Ordinance AFS, Vol. 3.
70. National Institute for Occupational Safety and Health. 2005. d-Limonene. http://www.cdc. gov/niosh/ipcsneng/neng0918.html (accessed August 5, 2012).
71. 1 mice. NTP TR 347, 1-165. http://ntp.niehs.nih.gov/ntp/htdocs/LT-rpts/tr347.pdf
72. Nilsson, U., Magnusson, K., Karlberg, O., and Karlberg, A. T. 1999. Are contact allergens stable in patch test preparations? Investigation of the degradation of d-limonene hydroperoxides in petrolatum. Contact Dermatitis 40: 127-132.
73. Nøjgaard, J. K., Christensen, K. B., and Wolkoff, P. 2005. The effect on human eye blink frequency of exposure to limonene oxidation products and methacrolein. Toxicol. Lett. 156: 241-251.
74. Okabe, H., Obata, Y., Takayama, K., and Nagai, T. 1990. Percutaneous absorption enhancing effect and skin irritation of mono-cyclic monoterpenes. Drug Design Deliv. 6: 229-238.
75. Olson, M. J., Johnson, J. T., and Reidy, C. A. 1990. A comparison of male rat and human urinary proteins: Implications for human resistance to hyaline droplet nephropathy. Toxicol. Appl. Pharmacol. 102: 524-536.
76. Opdyke, D. L. 1979. Monographs on fragrance raw materials. Food Cosmet. Toxicol. 17: 241-275.
77. Oshiro, Y., Balwierz, P. S., Eurell, T. E., Morris, D. L., and Alden, C. L. 1998. Exploration of the transformation potential of a unique male rat protein alpha2u-globulin using hamster embryonic cells. Toxicol. Pathol. 26: 381-387.
78. Pellizzari, E. D., Hartwell, T. D., Harris, B. S. H., Waddell, R. D., Whitaker, D. A., and Erickson, M. D. 1982. Purgeable organic compounds in mother's milk. Bull. Environ. Contam.Toxicol. 28: 322-328.
79. Pienta, R. 1980. Evaluation and relevance of the Syrian hamster embryo cell system. Appl. Met. Oncol. 3: 149-169.
80. Poon, G., Vigushin, D., Griggs, L., Rowlands, M., Coombes, R., and Jarman, M. 1996. Identification and characterization of limonene metabolites in patients with advanced cancer by liquid chromatography/mass spectrometry. Drug Metab. Dispos 24: 565-571.
81. Rabi, T., and Bishayee, A. 2009.d-limonene sensitizes docetaxel-induced cytotoxicity in human prostate cancer cells: Generation of reactive oxygen species and induction of apoptosis. J. Carcinogen. 8: 1-9.
82. Roberts, J. M., Hahn, C. J., Fehsenfeld, F. C., Warnock, J. M., Albritton, D. L., and Sievers, R. E. 1985.Monoterpene hydrocarbons in the nighttime troposphere. Environ. Sci. Technol. 19: 364-369.
83. Rolseth, V., Djurhuus, R., and Svardal, A. M. 2002.Additive toxicity of limonene and 50% oxygen and the role of glutathione in detoxification in human lung cells. Toxicology 170: 75-88.
84. Rycroft, R. J. G. 1980. Allergic contact dermatitis from dipentene in honing oil. Contact Dermat. 6: 325-329.
85. Sauer, T. C. 1981. Volatile organic compounds in open ocean and coastal surface waters. Org. Geochem. 3: 91-101.
86. Schäfer, R., and Schäfer, W. 1982. Die perkutaneresorptionverschiedener Terpene-Menthol, campher, limonen, isobornylacetat, α-Pinen-ausbadezusätzen. Arzneim. Forsch. 32: 56-58.
87. Shaw, R. W., Crittenden, A. L., Stevens, R. K., Cronn, D. R., and Titov, V. S. 1983. Ambient concentrations of hydrocarbons from conifers in atmospheric gases and aerosol particles measured in soviet Georgia. Environ. Sci. Technol. 17: 389-395.
88. Singal, M., Vitale, D., and Smith, L. 2011. Fragranced products and VOCs. Environ. Health Perspect. 119: A200.
89. Steele, V. E., Kelloff, G. J., Wilkinson, B. P., and Arnold, J. T. 1990. Inhibition of transformation in cultured rat tracheal epithelial cells by potential chemopreventive agents. Cancer Res. 50: 2068-2074.
90. Strömvall, A. M. 1992. Terpenes emitted to air from forestry and the forest industry. Göteborg, Sweden: Chalmers University of Technology. http://publications.lib.chalmers. se/records/fulltext/1519.pdf
91. Sun, J. 2007. d-Limonene: Safety and clinical applications. Altern. Med. Rev. 12: 259-264.
92. Tsuji, M., Fujisaki, Y., Yamachika, K., Nakagami, K., Fujisaka, F., Mito, M., Aoki, T., Kinoshita, S., Okubo, A., and Watanabe, I. 1974. Studies on d-limonene, as gallstone solubilizer (I): General pharmacological studies. Oyo Yakuri 8: 1439-1459.
93. Tsuji, M., Fujisaki, Y., Okubo, A., Arikawa, Y., Noda, K., Ide, H., and Ikeda, T. 1975a. Studies on d-limonene, as gallstone sol-ubilizer (V): Effects on development of rat fetuses and offspring. Oyo Yakuri 9: 179-186.
94. Tsuji, M., Fujisaki, Y., Arikawa, K., Masuda, S., Tanaka, T., Sato, K., Noda, K., Ide, H., and Kikuchi, M. 1975b. Studies on d-limonene, as gallstone solubilizer (IV): Chronic toxicity in dogs. Oyo Yakuri 9: 775-808.
95. U.S. Environmental Protection Agency. 1994. Limonene. EPA-738-F-94-030, 1-5. http://www.epa.gov/oppsrrd1/REDs/factsheets/3083fact.pdf
96. U.S. Environmental Protection Agency. 2004. Exposure and risk assessment on lower risk pesticide chemicals; d-Limonene. Arlington, VA: Office of Pesticide Programs. http://www.epa.gov/oppsrrd1/REDs/limonene-tred.pdf
97. U.S. Food and Drug Administration. 2011. Synthetic flavoring substances and adjuvants. 21 CFR §182.60. http://www.accessdata. fda.gov/scripts/cdrh/ cfdocs/cfcfr/CFRSearch. cfm?fr=182.60
98. U.S. Food and Drug Administration. 2012. General. 21 CFR §700. http://ecfr.gpoaccess. gov/cgi/t/text/text-idx?c=ecfr&sid=89cf1d1 eb4f13f6dd2564e0158a77d48&rgn=div5& view=text&node=21:7.0.1.2. 10&idno=21
99. U.S. National Oceanic and Atmospheric Administration. 1992. d-Limonene. http://cameochemicals.noaa.gov/chemical/20568 (accessed March 19, 2012).
100. van der Werf, M., de Bont, J., and Leak, D. 1997. Opportunities in microbial biotransformation of monoterpenes. Adv. Biochem. Eng. Biotechnol. 55: 147-177.
101. Vigushin, D. M., Poon, G. K., Boddy, A., English, J., Halbert, G. W., Pagonis, C., Jarman, M., and Coombes, R. C. 1998. Phase I and pharmacokinetic study of d-limonene in patients with advanced cancer. Cancer Chemother. Pharmacol. 42:111-117.
102. Wallace, L., Nelson, W., Ziegenfus, R., Pellizzari, E., Michael, L., Whitmore, R., Zelon, H., Hartwell, T., Perritt, R., and Westerdahl, D. 1991. The Los Angeles TEAM study: Personal exposures, indoor-outdoor air concentrations, and breath concentrations of 25 volatile organic compounds. J. Expos. Anal. Environ. Epidemiol. 1: 157-192.
103. Walser, M. L., Park, J., Gomez, A. L., Russell, A. R., and Nizkorodov, S. A. 2007. Photochemical aging of secondary organic aerosol particles generated from the oxidation of d-limonene. J. Phys. Chem. A 111:1907-1913.
104. Watabe, T., Hiratsuka, A., Ozawa, N., and Isobe, M. 1981.A comparative study on the metabolism of d-limonene and 4-vinylcyclohex-1-ene by hepatic microsomes. Xenobiotica 11: 333-344.
105. Webb, D., Ridder, G., and Alden, C. 1989. Acute and subchronic nephrotoxicity of d-limonene in Fischer 344 rats. Food. Chem. Toxicol. 27: 639-649.
106. Webb, D., Kanerva, R., Hysell, D., Alden, C., and Lehman-McKeeman, L. 1990. Assessment of the subchronic oral toxicity of d-limonene in dogs. Food. Chem. Toxicol. 28: 669-675.
107. Whysner, J., and Williams, G. M. 1996. d-limonene mechanistic data and risk assessment: Absolute species-specific cytotoxicity, enhanced cell proliferation, and tumor promotion. Pharmacol Ther. 71: 127-136.
108. Wolkoff, P., Clausen, P. A., Larsen, K., Hammer, M., Larsen, S. T., and Nielsen, G. D. 2008. Acute airway effects of ozone-initiated d-limonene chemistry: importance of gaseous products. Toxicol Lett. 181: 171-176.
109. World Health Organization. 1998. Concise international chemical assessment document 5. Limonene. Geneva, Switzerland: International Programme on Chemical Safety, WHO. http://whqlibdoc.who.int/publications/1998/9241530057.pdf
110. Yoon, W. J., Lee, N. H., and Hyun, C. G. 2010. Limonene suppresses lipopolysaccharide-induced production of nitric oxide, prostaglandin E 2, and pro-inflammatory cytokines in RAW 264.7 macrophages. J. Oleo Sci. 59: 415-421.
111. York, M., Basketter, D., Cuthbert, J., and Neilson, L. 1995. Skin irritation testing in man for hazard assessment-Evaluation of four patch systems. Hum. Exp. Toxicol. 14: 729-734.
112. Zhou, W., Yoshioka, M., and Yokogoshi, H. 2009. Sub-chronic effects of s-limonene on brain neurotransmitter levels and behavior of rats. J. Nutr. Sci. Vitaminol. (To k y o ) 55: 367-373.